← Back to headlines
Mizuho Adjusts Stock Targets for Assembly Biosciences, BridgeBio, and Intuit
Mizuho Securities revised its financial projections for multiple firms, cutting the price target for Assembly Biosciences, upgrading BridgeBio Pharma based on clinical developments, and reaffirming its rating for Intuit amid shifting fiscal forecasts.
31 Aug, 18:46 — 31 Aug, 18:46
Sources
Showing 1 of 1 sources
